The most important financial indicators for the company Ingenium Pharm Med Srl - Unique Identification Number 30232274:
sales in 2023 was
25
euro, registering a net profit of
1
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Intermedieri in comertul cu produse diverse having the NACE code 4619.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -99.9%, from 20.172 euro in the year 2022, to 25 euro in 2023.
The Net Profit decreased by -19.091 euro, from 19.150 euro in 2022, to 1 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ingenium Pharm Med Srl - CUI 30232274
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
7.428
6.498
5.451
5.358
5.260
4.980
10.628
11.566
12.460
12.422
Current Assets
3.517
5.838
5.878
5.821
5.750
8.676
20.603
10.328
30.337
28.552
Inventories
773
572
617
607
595
1.098
1.385
2.013
2.560
2.552
Receivables
2.465
5.259
5.249
5.165
5.064
7.575
19.194
8.313
27.748
25.860
Cash
279
7
12
49
91
2
24
2
30
140
Shareholders Funds
5.307
4.669
2.915
2.895
2.877
9.267
25.882
14.732
33.927
33.826
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
5.638
7.667
8.414
8.284
8.133
4.389
5.349
7.163
8.870
7.149
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
28.552 euro in 2023 which includes Inventories of
2.552 euro, Receivables of
25.860 euro and cash availability of
140 euro.
The company's Equity was valued at
33.826 euro, while total Liabilities amounted to
7.149 euro.
Equity increased by 1 euro, from 33.927 euro in 2022, to 33.826 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ingenium Pharm Med Srl